To further decipher the molecular signaling network involved in CEP55 accelerating the proliferation and survival of gallbladder cancer cells, we employed immunofluorescence assays to detect the effect of downregulation of CEP55 on AKT and ERK-dependent signaling pathways. The gene discussed is CEP55; the disease is gallbladder cancer.